References
- RossS, KrebsK, PareG, MilaniL. Pharmacogenomics in stroke and cardiovascular disease: state of the art. Stroke 54(1), 270–278 (2023).
- TalebiZ, SparreboomA, ColaceSI. Pharmacogenomics in cytotoxic chemotherapy of cancer. Methods Mol. Biol. 2547, 63–94 (2022).
- ScudelerMM, ManochioC, BragaPinto AJ, SantosCirino HD, da SilvaCS, Rodrigues-SoaresF. Breast cancer pharmacogenetics: a systematic review. Pharmacogenomics 24(2), 107–122 (2023).
- OslinDW, LynchKG, ShihMCet al. Effect of pharmacogenomic testing for drug–gene interactions on medication selection and remission of symptoms in major depressive disorder: the PRIME care randomized clinical trial. JAMA 328(2), 151–161 (2022).
- SwenJJ, vander Wouden CH, MansonLEet al. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Lancet 401(10374), 347–356 (2023).
- RellingMV, KleinTE. CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network. Clin. Pharmacol. Ther. 89(3), 464–467 (2011).
- Clinical Pharmacogenetics Implementation Consortium Guidelines. https://cpicpgx.org/guidelines/ (Accessed 16 August 2023 ).
- Dutch Pharmacogenetics Working Group Guidelines. www.knmp.nl/dossiers/farmacogenetica (Accessed 16 August 2023 ).
- Chanfreau-CoffinierC, HullLE, LynchJAet al. Projected prevalence of actionable pharmacogenetic variants and level a drugs prescribed among US Veterans Health Administration Pharmacy users. JAMA Netw. Open 2(6), e195345 (2019).
- MooreVR, GlassmanPA, AuA, GoodCB, LeadholmTC, CunninghamFE. Adverse drug reactions in the Veterans Affairs healthcare system: frequency, severity, and causative medications analyzed by patient age. Am. J. Health Syst. Pharm. 76(5), 312–319 (2019).
- DongOM, BatesJ, Chanfreau-CoffinierCet al. Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program. Pharmacogenomics 22(3), 137–144 (2021).
- EcclesMP, MittmanBS. Welcome to Implementation Science. Implemen. Sci. 1(1), 1 (2006).
- DongOM, RobertsMC, WuRRet al. Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program at initial test sites. Pharmacogenomics 22(17), 1121–1133 (2021).
- WeinerBJ, LewisCC, StanickCet al. Psychometric assessment of three newly developed implementation outcome measures. Implemen. Sci. 12(1), 108 (2017).
- ProctorE, SilmereH, RaghavanRet al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm. Policy Ment. Health 38(2), 65–76 (2011).
- StecklerA, GoodmanRM, McLeroyKR, DavisS, KochG. Measuring the diffusion of innovative health promotion programs. Am. J. Health Promot. 6(3), 214–224 (1992).
- RahawiS, NaikH, BlakeKVet al. Knowledge and attitudes on pharmacogenetics among pediatricians. J. Hum. Genet 65(5), 437–444 (2020).
- OrlandoLA, SperberNR, VoilsCet al. Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network/’s Common Measures Working Group. Genet Med. 20(6), 655–663 (2018).
- JohansenTaber KA, DickinsonBD. Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties. Pharmgenom. Pers. Med. 7, 145–162 (2014).
- Dedoose Version 9.0.17, cloud application for managing, analyzing, and presenting qualitative and mixed method research data. SocioCultural Research Consultation, LLC (2021). www.dedoose.com
- MeyerVM, BenjamensS, MoumniME, LangeJFM, PolRA. Global overview of response rates in patient and health care professional surveys in surgery: a systematic review. Ann. Surg. 275(1), e75–e81 (2022).
- McLeodCC, KlabundeCN, WillisGB, StarkD. Health care provider surveys in the United States, 2000–2010: a review. Eval. Health Prof. 36(1), 106–126 (2013).
- HaidarCE, PetryN, OxencisC, DouglasJS, HoffmanJM. ASHP statement on the pharmacist’s role in clinical pharmacogenomics. Am. J. Health Syst. Pharm. 79(8), 704–707 (2022).
- WellsDL, PopishS, KayC, TorriseV, ChristopherMLD. VA academic detailing service: implementation and lessons learned. Fed. Pract. 33(5), 38–42 (2016).